PMC:7799377 / 38799-39618
Annnotations
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T260 | 0-136 | Sentence | denotes | Treating neurological symptoms can be challenging as drugs that suppress the immune system may be contraindicated for COVID-19 patients. |
T261 | 137-224 | Sentence | denotes | There is evidence that the use of corticosteroids may prolong viral shedding [119,120]. |
T262 | 225-547 | Sentence | denotes | Symptoms for neurological problems may be addressed, with first-line strategies such as controlling body temperature, offering anticonvulsants, and treating hypoxia.21 Second-line treatments for neuroinflammation involve IV immunoglobulin or plasma exchange, but IV immunoglobulin may increase the risk of thromboembolism. |
T263 | 548-652 | Sentence | denotes | Furthermore, there is emerging concern of the possibility of microthrombosis in COVID-19 patients [121]. |
T264 | 653-819 | Sentence | denotes | Third-line strategies for neuroinflammation in COVID patients may carry higher risks, and include such pharmacological agents as cyclophosphamide and rituximab [121]. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T189 | 382-389 | Phenotype | denotes | hypoxia | http://purl.obolibrary.org/obo/HP_0012418 |
T190 | 531-546 | Phenotype | denotes | thromboembolism | http://purl.obolibrary.org/obo/HP_0001907 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1370 | 127-135 | Species | denotes | patients | Tax:9606 |
1371 | 637-645 | Species | denotes | patients | Tax:9606 |
1372 | 706-714 | Species | denotes | patients | Tax:9606 |
1373 | 782-798 | Chemical | denotes | cyclophosphamide | MESH:D003520 |
1374 | 803-812 | Chemical | denotes | rituximab | MESH:D000069283 |
1375 | 9-30 | Disease | denotes | neurological symptoms | MESH:D009422 |
1376 | 118-126 | Disease | denotes | COVID-19 | MESH:C000657245 |
1377 | 382-389 | Disease | denotes | hypoxia | MESH:D000860 |
1378 | 420-437 | Disease | denotes | neuroinflammation | MESH:D020078 |
1379 | 531-546 | Disease | denotes | thromboembolism | MESH:D013923 |
1380 | 609-624 | Disease | denotes | microthrombosis | |
1381 | 628-636 | Disease | denotes | COVID-19 | MESH:C000657245 |
1382 | 679-696 | Disease | denotes | neuroinflammation | MESH:D020078 |
1383 | 700-705 | Disease | denotes | COVID | MESH:C000657245 |